Interventional Oncology: Exploring the Boundaries

By Edward Kim, MD, FSIR

Top Papers in Interventional Oncology: Year in Review

Summarizing significant recent publications and their potential impacts on the field.

By Christopher D. Malone, MD, and Tyler Sandow, MD

Combination Locoregional and Immunotherapy in Practice

Beau B. Toskich, MD, leads Rony Avritscher, MD; Kirema Garcia-Reyes, MD; and Nora Tabori, MD, through a series of questions about their approaches to combining local therapy with immunotherapy, how/if recent data have impacted their decision-making, preferences on type of immunotherapy, emerging applications, and more.

TARE in Advanced HCC: When Is It Optimal and Why?

International perspectives on when to utilize transarterial radioembolization to increase the likelihood of curative outcomes in patients with advanced-stage hepatocellular carcinoma.

With Jin Woo Choi, MD, PhD, and Riad Salem, MD, MBA

MSK Ablation: Can We Push the Treatment Boundaries?

The evolving landscape of musculoskeletal interventional oncology treatment for the management of painful bone metastases.

By Jack Jennings, MD, PhD

Liver Ablation: Can We Push the Treatment Boundaries?

Current methods and cutting-edge technologies in liver ablation.

By Omid Shafaat, MD; Junaid Y. Raja, MD, MSPH, MS; Noreen Siddiqi, MD; Abin M. Sajan, MD; and Venkatesh P. Krishnasamy, MD, FCIRSE

Renal Ablation: Can We Push the Treatment Boundaries?

Strategies for treatment based on size criteria, ablation modality, tumor location, periprocedural considerations, and combination therapy options.

By Ronak Patel, BS, and Merve Ozen, MD

An Interview With Marie Josee van Rijn, MD, PhD

Dr. van Rijn discusses her epidemiology background, the multidisciplinary nature of DVT treatment, tips for postthrombectomy acute iliofemoral venous thrombosis stenting, and more.